|
|
Generic version of Wellbutrin XL.(Updates)(drug for the treatment of major depressive disorder; Anchen Pharmaceuticals Inc.)(Brief article)
- Article from:
-
FDA Consumer
- Article date:
-
March 1, 2007
|
Copyright informationCOPYRIGHT 2007 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The FDA has approved the first generic version of Wellbutrin XL (bupropion hydrochloride) extended-release tablets. This drug is indicated for the treatment of major depressive disorder (MDD).
The approval, in December 2006, is an important step in the agency's effort to increase the availability of lower-cost generic medications. In 2005, Wellbutrin XL was the 21st highest-selling brand-name drug in the United States, with sales totaling more than $1.3 billion, according to the online magazine Drug Topics.
The FDA received a formal request for FDA action (citizen petition) that asked the agency to consider several issues for Bupropion ...